Literature DB >> 18770270

Induction of lymphoid leukosis transplant able tumours and the establishment of lymphoblastoid cell lines.

W Okazaki1, R L Witter, C Romero, K Nazerian, J M Sharma, A Fadly, D Ewert.   

Abstract

Primary lymphoid tumours induced by the subgroup A, B, C and D lymphoid leukosis viruses RAV-1, RAV-2, RAV-49 and RAV-50, respectively, have been developed as transplantable "B-cell" lymphoid tumours and designated LSCT-RP5, LSCT-RP6, LSCT-RP7 and LSCT-RP8, respectively. There seems little doubt that these are indeed transplants because all produce tumours and death of the inoculated chicks in a very short time (median days to death =5-10 days), and chromosome analyses reveal that the sex of the tumour cells remains unchanged when passaged in chicks of the opposite sex. We have established 2 in vitro lymphoblastoid lines (LSCC-RP9 and LSCC-RP12) from the RAV-2 transplantable tumour (LSCT-RP6), but were unsuccessful after numerous attempts with RAV-1 transplantable tumours (LSCT-RP5). The LSCC-RP9 and LSCC-RP12 lymphoblastoid cell lines grow rapidly and produce large amounts of virus. These transplantable tumours and lymphoblastoid cell lines should provide valuable materials for studies on virus-host and tumour cell-host interrelationships.

Entities:  

Year:  1980        PMID: 18770270     DOI: 10.1080/03079458008418416

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  10 in total

1.  Mass spectral data for 64 eluted peptides and structural modeling define peptide binding preferences for class I alleles in two chicken MHC-B haplotypes associated with opposite responses to Marek's disease.

Authors:  Mark A Sherman; Ronald M Goto; Roger E Moore; Henry D Hunt; Terry D Lee; Marcia M Miller
Journal:  Immunogenetics       Date:  2008-07-09       Impact factor: 2.846

2.  Cultivation of avian rotaviruses in chicken lymphocytes and lymphoblastoid cell lines.

Authors:  K A Schat; T J Myers
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Two class I genes of the chicken MHC have different functions: BF1 is recognized by NK cells while BF2 is recognized by CTLs.

Authors:  Taejoong Kim; Henry D Hunt; Mark S Parcells; Vicky van Santen; Sandra J Ewald
Journal:  Immunogenetics       Date:  2018-06-09       Impact factor: 2.846

4.  Analysis of B-L beta-chain gene expression in two chicken cDNA libraries.

Authors:  G T Pharr; L D Bacon; J B Dodgson
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Linkage of a new member of the lectin supergene family to chicken Mhc genes.

Authors:  A Bernot; R Zoorob; C Auffray
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  At least one YMHCI molecule in the chicken is alloimmunogenic and dynamically expressed on spleen cells during development.

Authors:  Henry D Hunt; Ronald M Goto; Douglas N Foster; Larry D Bacon; Marcia M Miller
Journal:  Immunogenetics       Date:  2006-03-28       Impact factor: 2.846

7.  Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis.

Authors:  J L Liu; Y Ye; L F Lee; H J Kung
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.

Authors:  E Le Rouzic; P Thoraval; M Afanassieff; Y Cherel; G Dambrine; B Perbal
Journal:  Mol Pathol       Date:  2002-08

9.  V-myc- and c-myc-encoded proteins are associated with the nuclear matrix.

Authors:  R N Eisenman; C Y Tachibana; H D Abrams; S R Hann
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

10.  Leukocyte Immunoglobulin-Like Receptors A2 and A6 are Expressed in Avian Macrophages and Modulate Cytokine Production by Activating Multiple Signaling Pathways.

Authors:  Anh Duc Truong; Deivendran Rengaraj; Yeojin Hong; Ha Thi Thanh Tran; Hoang Vu Dang; Viet Khong Nguyen; Hyun S Lillehoj; Yeong Ho Hong
Journal:  Int J Mol Sci       Date:  2018-09-11       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.